Globus Medical (GMED) EV to EBIT (2012 - 2026)

Globus Medical (GMED) has reported EV to EBIT for 15 consecutive years, with 54.89 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to EBIT fell 46.04% year-over-year to 54.89; the trailing twelve-month figure through Jun 2026 stood at 15.66 (down 43.07% YoY), and the FY2025 full-year result was 23.45, down 62.88% from the prior year.
• EV to EBIT eased to 54.89 in Q2 2026 per GMED's latest filing, from 73.58 in the prior quarter.
• Across five years, EV to EBIT topped out at 16118.46 in Q3 2023 and bottomed at 52.96 in Q3 2025.
• Historically, EV to EBIT has averaged 1068.93 across 5 years, with a median of 99.56 in 2025.
• The sharpest annual moves came in 2023 and 2024: EV to EBIT surged 17262.79% in 2023, then tumbled 98.83% in 2024.
• Over 5 years, EV to EBIT stood at 129.63 in 2022, then jumped by 410.3% to 661.48 in 2023, then tumbled by 73.7% to 173.97 in 2024, then slumped by 61.81% to 66.44 in 2025, then retreated by 17.4% to 54.89 in 2026.
• According to Business Quant data, EV to EBIT over the past three periods registered 54.89, 73.58, and 66.44 for Q2 2026, Q1 2026, and Q4 2025 respectively.